Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-08
2008-12-02
Tsang, Cecilia (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000
Reexamination Certificate
active
07459430
ABSTRACT:
The invention relates to methods of using Cav2.2 subunit calcium channel modulators to treat painful and non-painful lower urinary tract disorders and the related genitourinary tract disorders vulvodynia and vulvar vestibulitis in normal and spinal cord injured patients.
REFERENCES:
patent: 5670622 (1997-09-01), Shon et al.
patent: 5698549 (1997-12-01), Steers et al.
patent: 5739276 (1998-04-01), Shon et al.
patent: 6077680 (2000-06-01), Kem et al.
patent: 6190691 (2001-02-01), Mak
patent: 7084116 (2006-08-01), Fraser et al.
patent: 1 042 468 (2000-10-01), None
patent: 1 117 680 (2001-07-01), None
patent: 11035483 (1999-02-01), None
patent: WO 95/23132 (1995-08-01), None
patent: WO 96/33206 (1996-10-01), None
patent: WO 98/23639 (1998-06-01), None
patent: WO 99/28342 (1999-06-01), None
patent: WO 00/18402 (2000-04-01), None
patent: WO 00/18801 (2000-04-01), None
patent: WO 03/018561 (2003-03-01), None
patent: WO 2004/054560 (2004-07-01), None
Catterall, W.A., “Structure and Regulation of Voltage-Gated Ca2+Channels,”Annu. Rev. Cell Dev. Biol., 2000, pp. 521-555, vol. 16.
Guido, M. III, et al., “Clinical Experience with Levetiracetam,”Epilepsia, 2001, p. 180, vol. 42(7).
Maggi, C.A., et al., “Effect of Omega Conotoxin on Reflex Responses Mediated by Activiation of Capsaicin-Sensitive Nerves of the Rat Urinary Bladder and Peptide Release from the Rat Spinal Cord,”Neuroscience, 1990, pp. 243-250, vol. 34(1).
Burgard Edward C.
Fraser Matthew Oliver
Thor Karl Bruce
Alston & Bird LLP
Dynogen Pharmaceuticals, Inc.
Gudibande Satyanarayana
Tsang Cecilia
LandOfFree
Methods of using ziconotide to treat overactive bladder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of using ziconotide to treat overactive bladder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using ziconotide to treat overactive bladder will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4052032